Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Biol Res ; 51(1): 34, 2018 Sep 15.
Article in English | MEDLINE | ID: mdl-30219096

ABSTRACT

BACKGROUND AND AIMS: Atherosclerotic cardiovascular disease is highly prevalent and its underlying pathogenesis involves dyslipidemia including pro-atherogenic high density lipoprotein (HDL) remodeling. Vitamins C and E have been proposed as atheroprotective agents for cardiovascular disease management. However, their effects and benefits on high density lipoprotein function and remodeling are unknown. In this study, we evaluated the role of vitamin C and E on non HDL lipoproteins as well as HDL function and remodeling, along with their effects on inflammation/oxidation biomarkers and atherosclerosis in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice. METHODS AND RESULTS: Mice were pre-treated for 5 weeks before and during atherogenic diet feeding with vitamin C and E added to water and diet, respectively. Compared to a control group, combined vitamin C and E administration reduced serum total cholesterol and triglyceride levels by decreasing apo B-48-containing lipoproteins, remodeled HDL particles by reducing phospholipid as well as increasing PON1 and apo D content, and diminished PLTP activity and levels. Vitamin supplementation improved HDL antioxidant function and lowered serum TNF-α levels. Vitamin C and E combination attenuated atherogenesis and increased lifespan in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice. CONCLUSIONS: Vitamin C and E administration showed significant lipid metabolism regulating effects, including HDL remodeling and decreased levels of apoB-containing lipoproteins, in mice. In addition, this vitamin supplementation generated a cardioprotective effect in a murine model of severe and lethal atherosclerotic ischemic heart disease.


Subject(s)
Antioxidants/pharmacology , Apolipoprotein B-48/drug effects , Ascorbic Acid/pharmacology , Hyperlipidemias/prevention & control , Lipoproteins, HDL/drug effects , Myocardial Ischemia/prevention & control , Vitamin E/pharmacology , Animals , Apolipoprotein B-48/blood , Cardiotonic Agents/pharmacology , Coronary Artery Disease/blood , Coronary Artery Disease/prevention & control , Cytokines/blood , Diet, Atherogenic , Dietary Supplements , Enzyme-Linked Immunosorbent Assay , Female , Hyperlipidemias/blood , Immunoblotting , Lipid Metabolism/drug effects , Lipoproteins, HDL/blood , Male , Mice, Inbred C57BL , Myocardial Ischemia/blood , Phospholipid Transfer Proteins/blood , Reference Values , Reproducibility of Results , Scavenger Receptors, Class B/blood , Scavenger Receptors, Class B/drug effects , Treatment Outcome
2.
Biol. Res ; 51: 34, 2018. tab, graf
Article in English | LILACS | ID: biblio-983938

ABSTRACT

BACKGROUND AND AIMS: Atherosclerotic cardiovascular disease is highly prevalent and its underlying pathogenesis involves dyslipidemia including pro-atherogenic high density lipoprotein (HDL) remodeling. Vitamins C and E have been proposed as atheroprotective agents for cardiovascular disease management. However, their effects and benefits on high density lipoprotein function and remodeling are unknown. In this study, we evaluated the role of vitamin C and E on non HDL lipoproteins as well as HDL function and remodeling, along with their effects on inflammation/ oxidation biomarkers and atherosclerosis in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice. METHODS AND RESULTS: Mice were pre-treated for 5 weeks before and during atherogenic diet feeding with vitamin C and E added to water and diet, respectively. Compared to a control group, combined vitamin C and E administration reduced serum total cholesterol and triglyceride levels by decreasing apo B-48-containing lipoproteins, remodeled HDL particles by reducing phospholipid as well as increasing PON1 and apo D content, and diminished PLTP activity and levels. Vitamin supplementation improved HDL antioxidant function and lowered serum TNF-α levels. Vitamin C and E combination attenuated atherogenesis and increased lifespan in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice. CONCLUSIONS: Vitamin C and E administration showed significant lipid metabolism regulating effects, including HDL remodeling and decreased levels of apoB-containing lipoproteins, in mice. In addition, this vitamin supplementation generated a cardioprotective effect in a murine model of severe and lethal atherosclerotic ischemic heart disease.


Subject(s)
Animals , Male , Female , Ascorbic Acid/pharmacology , Vitamin E/pharmacology , Myocardial Ischemia/prevention & control , Apolipoprotein B-48/drug effects , Hyperlipidemias/prevention & control , Lipoproteins, HDL/drug effects , Antioxidants/pharmacology , Reference Values , Coronary Artery Disease/prevention & control , Coronary Artery Disease/blood , Enzyme-Linked Immunosorbent Assay , Cardiotonic Agents/pharmacology , Immunoblotting , Reproducibility of Results , Cytokines/blood , Treatment Outcome , Myocardial Ischemia/blood , Dietary Supplements , Phospholipid Transfer Proteins/blood , Diet, Atherogenic , Scavenger Receptors, Class B/drug effects , Scavenger Receptors, Class B/blood , Lipid Metabolism/drug effects , Apolipoprotein B-48/blood , Hyperlipidemias/blood , Lipoproteins, HDL/blood , Mice, Inbred C57BL
3.
J Diabetes Res ; 2016: 3793781, 2016.
Article in English | MEDLINE | ID: mdl-27366756

ABSTRACT

High circulating nonesterified fatty acids (NEFAs) concentration, often reported in diabetes, leads to impaired glucose-stimulated insulin secretion (GSIS) through not yet well-defined mechanisms. Serotonin and dopamine might contribute to NEFA-dependent ß-cell dysfunction, since extracellular signal of these monoamines decreases GSIS. Moreover, palmitate-treated ß-cells may enhance the expression of the serotonin receptor Htr2c, affecting insulin secretion. Additionally, the expression of monoamine-oxidase type B (Maob) seems to be lower in islets from humans and mice with diabetes compared to nondiabetic islets, which may lead to increased monoamine concentrations. We assessed the expression of serotonin- and dopamine-related genes in islets from db/db and wild-type (WT) mice. In addition, the effect of palmitate and oleate on the expression of such genes, 5HT content, and GSIS in MIN6 ß-cell was determined. Lower Maob expression was found in islets from db/db versus WT mice and in MIN6 ß-cells in response to palmitate and oleate treatment compared to vehicle. Reduced 5HT content and impaired GSIS in response to palmitate (-25%; p < 0.0001) and oleate (-43%; p < 0.0001) were detected in MIN6 ß-cells. In conclusion, known defects of GSIS in islets from db/db mice and MIN6 ß-cells treated with NEFAs are accompanied by reduced Maob expression and reduced 5HT content.


Subject(s)
Insulin-Secreting Cells/drug effects , Islets of Langerhans/metabolism , Transcriptome/genetics , Acetylserotonin O-Methyltransferase/drug effects , Acetylserotonin O-Methyltransferase/genetics , Animals , Arylalkylamine N-Acetyltransferase/drug effects , Arylalkylamine N-Acetyltransferase/genetics , Catechol O-Methyltransferase/drug effects , Catechol O-Methyltransferase/genetics , Cell Line , Dopa Decarboxylase/drug effects , Dopa Decarboxylase/genetics , Dopamine Plasma Membrane Transport Proteins/drug effects , Dopamine Plasma Membrane Transport Proteins/genetics , Dopamine beta-Hydroxylase/drug effects , Dopamine beta-Hydroxylase/genetics , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/metabolism , Mice , Monoamine Oxidase/drug effects , Monoamine Oxidase/genetics , Oleic Acid/pharmacology , Palmitic Acid/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Serotonin/metabolism , Serotonin Plasma Membrane Transport Proteins/drug effects , Serotonin Plasma Membrane Transport Proteins/genetics , Transcriptome/drug effects , Tryptophan Hydroxylase/drug effects , Tryptophan Hydroxylase/genetics , Tyrosine 3-Monooxygenase/drug effects , Tyrosine 3-Monooxygenase/genetics
4.
Mol Hum Reprod ; 20(4): 341-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24334245

ABSTRACT

Human epididymal CRISP1 (hCRISP1) associates with sperm during maturation and participates in gamete fusion through egg complementary sites. Its homology with both rodent epididymal CRISP1 and CRISP4 reported to participate in the previous stage of sperm binding to the zona pellucida (ZP), led us to further investigate the functional role of hCRISP1 by studying its involvement in human sperm-ZP interaction. Human hemizona (HZ) were inseminated with human capacitated sperm in the presence of either anti-hCRISP1 polyclonal antibody to inhibit sperm hCRISP1, or bacterially-expressed hCRISP1 (rec-hCRISP1) to block putative hCRISP1 binding sites in the ZP. Results revealed that both anti-hCRISP1 and rec-hCRISP1 produced a significant inhibition in the number of sperm bound per HZ compared with the corresponding controls. The finding that neither anti-hCRISP1 nor rec-hCRISP1 affected capacitation-associated events (i.e. sperm motility, protein tyrosine phosphorylation or acrosome reaction) supports a specific inhibition at the sperm-egg interaction level. Moreover, immunofluorescence experiments using human ZP-intact eggs revealed the presence of complementary sites for hCRISP1 in the ZP. To identify the ligand of hCRISP1 in the ZP, human recombinant proteins ZP2, ZP3 and ZP4 expressed in insect cells were co-incubated with hCRISP1 and protein-protein interaction was analyzed by ELISA. Results revealed that rec-hCRISP1 mainly interacted with ZP3 in a dose-dependent and saturable manner, supporting the specificity of this interaction. Altogether, these results indicate that hCRISP1 is a multifunctional protein involved not only in sperm-egg fusion but also in the previous stage of sperm-ZP binding through its specific interaction with human ZP3.


Subject(s)
Egg Proteins/genetics , Membrane Glycoproteins/genetics , Receptors, Cell Surface/genetics , Sperm Capacitation/genetics , Spermatozoa/metabolism , Zona Pellucida/metabolism , Acrosome Reaction/drug effects , Adult , Antibodies/pharmacology , Binding Sites , Binding, Competitive , Egg Proteins/metabolism , Egg Proteins/pharmacology , Epididymis/cytology , Epididymis/drug effects , Epididymis/metabolism , Female , Gene Expression Regulation , Humans , Male , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/metabolism , Membrane Glycoproteins/pharmacology , Protein Binding , Receptors, Cell Surface/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Signal Transduction , Sperm Capacitation/drug effects , Spermatozoa/cytology , Spermatozoa/drug effects , Zona Pellucida/drug effects , Zona Pellucida Glycoproteins
5.
Mol Cell Endocrinol ; 315(1-2): 299-307, 2010 Feb 05.
Article in English | MEDLINE | ID: mdl-19883728

ABSTRACT

Niemann Pick C2 (NPC2) and NPC1 proteins function cooperatively to catalyze cholesterol efflux from lysosomes. NPC1 is expressed in ovarian cells and female NPC1 mice are infertile. This work addressed for the first time the localization and function of murine NPC2 protein in the ovary. Ovarian NPC2 was localized to theca and luteal cells, which use cholesterol as a substrate to produce estradiol and progesterone, respectively. NPC2 deficient (NPC2-/-) females had abnormal estrous cycles and were infertile, with normal folliculogenesis until the antral stage, but a complete absence of corpora lutea and many zonae pellucidae remnants, indicative of anovulation. Serum estradiol was reduced and ovarian cholesterol was accumulated in NPC2-/- mice, suggesting a defect in cholesterol export from intracellular stores. After superovulation, NPC2-/- mice ovulated less eggs than their wild type littermates, showed ovaries with less corpora lutea and numerous unruptured follicles, and lower serum progesterone concentration. Together, these results suggest that NPC2 participates in the traffic of ovarian cholesterol required to provide the substrate for steroid synthesis and support follicle maturation, ovulation and luteinization.


Subject(s)
Anovulation , Infertility, Female/etiology , Steroids/biosynthesis , Vesicular Transport Proteins/metabolism , Animals , Anovulation/complications , Anovulation/genetics , Cholesterol/metabolism , Female , Infertility, Female/physiopathology , Luteinization/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Ovary/anatomy & histology , Ovary/physiology , Vesicular Transport Proteins/genetics
6.
Cell Death Differ ; 15(8): 1211-20, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18274553

ABSTRACT

Translationally controlled tumor protein (TCTP) is a potential target for cancer therapy. It functions as a growth regulating protein implicated in the TSC1-TSC2 -mTOR pathway or a guanine nucleotide dissociation inhibitor for the elongation factors EF1A and EF1Bbeta. Accumulating evidence indicates that TCTP also functions as an antiapoptotic protein, through a hitherto unknown mechanism. In keeping with this, we show here that loss of tctp expression in mice leads to increased spontaneous apoptosis during embryogenesis and causes lethality between E6.5 and E9.5. To gain further mechanistic insights into this apoptotic function, we solved and refined the crystal structure of human TCTP at 2.0 A resolution. We found a structural similarity between the H2-H3 helices of TCTP and the H5-H6 helices of Bax, which have been previously implicated in regulating the mitochondrial membrane permeability during apoptosis. By site-directed mutagenesis we establish the relevance of the H2-H3 helices in TCTP's antiapoptotic function. Finally, we show that TCTP antagonizes apoptosis by inserting into the mitochondrial membrane and inhibiting Bax dimerization. Together, these data therefore further confirm the antiapoptotic role of TCTP in vivo and provide new mechanistic insights into this key function of TCTP.


Subject(s)
Apoptosis , Biomarkers, Tumor/chemistry , Biomarkers, Tumor/metabolism , Mitochondria/metabolism , bcl-2-Associated X Protein/metabolism , Amino Acid Sequence , Animals , Biomarkers, Tumor/genetics , Cell Line , Crystallography, X-Ray , Dimerization , Embryonic Development , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Mutation , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Alignment , Tumor Protein, Translationally-Controlled 1 , bcl-2-Associated X Protein/chemistry
7.
Soc Reprod Fertil Suppl ; 65: 353-6, 2007.
Article in English | MEDLINE | ID: mdl-17644975

ABSTRACT

Epididymal protein DE and testicular protein Tpx-1 are two cysteine-rich secretory proteins also known as CRISP-1 and CRISP-2, respectively. DE/ CRISP-1 is localised on the equatorial segment of acrosome-reacted sperm and participates in rat gamete fusion through its binding to egg-complementary sites. Recent results using bacterially-expressed recombinant fragments of DE as well as synthetic peptides revealed that the ability of DE to bind to the egg surface and inhibit gamete fusion resides in a region of 12 amino acids corresponding to an evolutionary conserved motif of the CRISP family (Signature 2). Given the high degree of homology between DE/CRISP-1 and Tpx-1/CRISP-2, we also explored the potential participation of the testicular intra-acrosomal protein in gamete fusion. Results showing the ability of recombinant Tpx-1 to bind to the surface of rat eggs (evaluated by indirect immunofluorescence) and to significantly inhibit zona-free egg penetration, support the participation of this protein in gamete fusion through its interaction with egg-binding sites. Interestingly, rat Tpx-1 exhibits only two substitutions in Signature 2 when compared to this region in DE. Together, these results provide evidence for the involvement of both epididymal DE/CRISP-1 and testicular Tpx-1/CRISP-2 in gamete fusion suggesting the existence of a functional cooperation between homologue molecules as a mechanism to ensure the success of fertilisation.


Subject(s)
Membrane Glycoproteins/metabolism , Sperm-Ovum Interactions/physiology , Acrosome Reaction/physiology , Animals , Cell Adhesion Molecules , Female , Glycoproteins/metabolism , Humans , Male , Ovum/metabolism , Spermatozoa/metabolism
8.
Acta Crystallogr D Biol Crystallogr ; 62(Pt 10): 1103-13, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17001088

ABSTRACT

The implementation of high-throughput (HTP) cloning and expression screening in Escherichia coli by 14 laboratories in the Structural Proteomics In Europe (SPINE) consortium is described. Cloning efficiencies of greater than 80% have been achieved for the three non-ligation-based cloning techniques used, namely Gateway, ligation-indendent cloning of PCR products (LIC-PCR) and In-Fusion, with LIC-PCR emerging as the most cost-effective. On average, two constructs have been made for each of the approximately 1700 protein targets selected by SPINE for protein production. Overall, HTP expression screening in E. coli has yielded 32% soluble constructs, with at least one for 70% of the targets. In addition to the implementation of HTP cloning and expression screening, the development of two novel technologies is described, namely library-based screening for soluble constructs and parallel small-scale high-density fermentation.


Subject(s)
Cloning, Molecular/methods , Prokaryotic Cells/metabolism , Proteomics/trends , Amino Acid Sequence , Automation , Base Sequence , Escherichia coli/metabolism , Europe , Fermentation , Gene Deletion , Gene Library , Genetic Vectors , Molecular Sequence Data , Protein Folding , Sequence Analysis/instrumentation , Sequence Analysis/methods
9.
Acta Crystallogr D Biol Crystallogr ; 62(Pt 10): 1114-24, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17001089

ABSTRACT

The production of sufficient quantities of protein is an essential prelude to a structure determination, but for many viral and human proteins this cannot be achieved using prokaryotic expression systems. Groups in the Structural Proteomics In Europe (SPINE) consortium have developed and implemented high-throughput (HTP) methodologies for cloning, expression screening and protein production in eukaryotic systems. Studies focused on three systems: yeast (Pichia pastoris and Saccharomyces cerevisiae), baculovirus-infected insect cells and transient expression in mammalian cells. Suitable vectors for HTP cloning are described and results from their use in expression screening and protein-production pipelines are reported. Strategies for co-expression, selenomethionine labelling (in all three eukaryotic systems) and control of glycosylation (for secreted proteins in mammalian cells) are assessed.


Subject(s)
Eukaryotic Cells/metabolism , Proteomics/methods , Animals , Baculoviridae/genetics , Cells, Cultured , Cloning, Molecular , Gene Expression , Glycosylation , Selenomethionine , Yeasts/metabolism
10.
Mol Hum Reprod ; 11(4): 299-305, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15734896

ABSTRACT

Testicular protein Tpx-1, also known as CRISP-2, is a cysteine-rich secretory protein specifically expressed in the male reproductive tract. Since the information available on the human protein is limited to the identification and expression of its gene, in this work we have studied the presence and localization of human Tpx-1 (TPX1) in sperm, its fate after capacitation and acrosome reaction (AR), and its possible involvement in gamete interaction. Indirect immunofluorescence studies revealed the absence of significant staining in live or fixed non-permeabilized sperm, in contrast to a clear labelling in the acrosomal region of permeabilized sperm. These results, together with complementary evidence from protein extraction procedures strongly support that TPX1 would be mainly an intra-acrosomal protein in fresh sperm. After in vitro capacitation and ionophore-induced AR, TPX1 remained associated with the equatorial segment of the acrosome. The lack of differences in the electrophoretic mobility of TPX1 before and after capacitation and AR indicates that the protein would not undergo proteolytical modifications during these processes. The possible involvement of TPX1 in gamete interaction was evaluated by the hamster oocyte penetration test. The presence of anti-TPX1 during gamete co-incubation produced a significant and dose-dependent inhibition in the percentage of penetrated zona-free hamster oocytes without affecting sperm motility, the AR or sperm binding to the oolema. Together, these results indicate that human TPX1 would be a component of the sperm acrosome that remains associated with sperm after capacitation and AR, and is relevant for sperm-oocyte interaction.


Subject(s)
Glycoproteins/analysis , Glycoproteins/metabolism , Sperm Capacitation/physiology , Sperm-Ovum Interactions/physiology , Spermatozoa/chemistry , Antibodies/pharmacology , Cell Adhesion Molecules , Glycoproteins/antagonists & inhibitors , Humans , Male , Sperm-Ovum Interactions/drug effects , Spermatozoa/drug effects , Spermatozoa/metabolism
11.
Cell Mol Biol (Noisy-le-grand) ; 49(3): 407-12, 2003 May.
Article in English | MEDLINE | ID: mdl-12887093

ABSTRACT

Protein DE (32 kDa) associates with sperm during epididymal maturation and participates in sperm-egg fusion through its binding to complementary sites on the egg surface. In the present work we investigated the participation of DE in two mechanisms probably involved in egg activation: the ability of DE to trigger activation by its interaction with the binding sites on the egg surface (receptor model) and its ability to regulate intracellular calcium channels (sperm factor model). The incubation of eggs with DE did not promote activation parameters such as calcium oscillations or meiosis resumption. Secondly, microinjection of DE into eggs was ineffective in either eliciting calcium release or modifying oscillations induced by an activating sperm extract. Together, these results argue against the participation of DE in egg activation, restricting the activity of this protein and its egg binding sites to the sperm-egg fusion process.


Subject(s)
Epididymal Secretory Proteins/physiology , Membrane Glycoproteins/physiology , Ovum/physiology , Sperm-Ovum Interactions/physiology , Animals , Calcium/metabolism , Female , Fertilization , Fertilization in Vitro , Fluorescent Antibody Technique, Indirect , Male , Membrane Glycoproteins/pharmacology , Mice , Mice, Inbred Strains , Microinjections , Oocytes/chemistry , Oocytes/drug effects , Oocytes/physiology , Ovum/metabolism , Rats , Rats, Sprague-Dawley , Species Specificity , Sperm Capacitation , Spermatozoa/chemistry , Spermatozoa/drug effects , Spermatozoa/physiology
12.
Arch Med Res ; 32(6): 614-8, 2001.
Article in English | MEDLINE | ID: mdl-11750738

ABSTRACT

Fusion between gametes is a key event in the fertilization process involving the interaction of specific domains of the sperm and egg plasma membranes. During recent years, efforts have been made toward the identification of the specific molecular components involved in this event. The present work will focus on the best characterized candidates for mediating gamete membrane fusion in mammals. These molecules include members of the ADAM (a disintegrin and a metalloprotease domain) family, i.e., testicular proteins fertilin alpha, fertilin beta, and cyritestin, which are thought to interact with integrins in the egg plasma membrane through their disintegrin domains, and a member of the cysteine-rich secretory proteins (CRISP) family, i.e., epididymal protein DE, which participates in an event subsequent to sperm-egg binding and leading to fusion through specific complementary sites localized on the fusogenic area of the egg surface. The identification and characterization of these molecules will contribute not only to a better understanding of the molecular mechanisms underlying mammalian sperm-egg fusion but also to the development of new methods for both fertility regulation and diagnosis and treatment of human infertility.


Subject(s)
Sperm-Ovum Interactions/physiology , ADAM Proteins , Animals , Cricetinae , Egg Proteins/physiology , Female , Fertilins , Glycoproteins/physiology , Humans , Male , Mammals/genetics , Mammals/physiology , Membrane Fusion , Membrane Glycoproteins/physiology , Mesocricetus , Metalloendopeptidases/physiology , Mice , Rats , Salivary Proteins and Peptides/physiology , Seminal Plasma Proteins/physiology , Species Specificity , Vaccines, Contraceptive , Zona Pellucida/physiology
13.
Biol Reprod ; 65(4): 1000-5, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11566719

ABSTRACT

Human epididymal sperm protein ARP, a member of the cysteine-rich secretory proteins (CRISP) family, exhibits significant homology with rat epididymal protein DE, a candidate molecule for mediating sperm-egg fusion in rodents. The aim of this study was to investigate the involvement of ARP in human gamete fusion. Sequential extraction of proteins from ejaculated human sperm revealed the existence of a population of ARP that is tightly associated with the sperm surface and thus, potentially capable of participating in gamete interaction. Exposure of capacitated human sperm to a polyclonal antibody against recombinant ARP (anti-ARP) produced a significant and concentration-dependent inhibition in the ability of human sperm to penetrate zona-free hamster eggs. This inhibition was not due to a deleterious effect on the gametes because anti-ARP affected neither sperm viability or motility, nor egg penetrability. The antibody did not inhibit the occurrence of spontaneous or Ca(2+) ionophore-induced acrosome reaction, nor did it inhibit the ability of sperm to bind to the oolema, supporting a specific inhibition of the antibody at the sperm-egg fusion level. As a relevant evidence for a role of ARP in gamete fusion, the existence of complementary sites for this protein on the surface of human eggs was investigated. Experiments in which zona-free human oocytes discarded from in vitro fertilization programs were exposed to ARP, fixed, and subjected to indirect immunofluorescence revealed the presence of specific ARP-binding sites on the entire surface of the human egg, in agreement with the fusogenic properties of the human oolema. Together, these results strongly support the participation of ARP in the sperm-egg fusion process, suggesting that this protein would be the functional homologue of DE in humans.


Subject(s)
Glycoproteins/physiology , Membrane Glycoproteins , Oocytes/chemistry , Salivary Proteins and Peptides/physiology , Seminal Plasma Proteins/physiology , Sperm-Ovum Interactions/physiology , Animals , Binding Sites , Blotting, Western , Cricetinae , Female , Fertilization in Vitro , Fluorescent Antibody Technique, Indirect , Glycoproteins/metabolism , Humans , Male , Oocytes/metabolism , Recombinant Proteins/metabolism , Salivary Proteins and Peptides/metabolism , Seminal Plasma Proteins/metabolism , Spermatozoa/metabolism
14.
J Biol Chem ; 276(10): 7457-64, 2001 Mar 09.
Article in English | MEDLINE | ID: mdl-11056162

ABSTRACT

The human MAT1 protein belongs to the cyclin-dependent kinase-activating kinase complex, which is functionally associated to the transcription/DNA repair factor TFIIH. The N-terminal region of MAT1 consists of a C3HC4 RING finger, which contributes to optimal TFIIH transcriptional activities. We report here the solution structure of the human MAT1 RING finger domain (Met(1)-Asp(65)) as determined by (1)H NMR spectroscopy. The MAT1 RING finger domain presents the expected betaalphabetabeta topology with two interleaved zinc-binding sites conserved among the RING family. However, the presence of an additional helical segment in the N-terminal part of the domain and a conserved hydrophobic central beta strand are the defining features of this new structure and more generally of the MAT1 RING finger subfamily. Comparison of electrostatic surfaces of RING finger structures shows that the RING finger domain of MAT1 presents a remarkable positively charged surface. The functional implications of these MAT1 RING finger features are discussed.


Subject(s)
Neoplasm Proteins/chemistry , Transcription Factors, TFII , Transcription Factors/chemistry , Amino Acid Sequence , Binding Sites , Conserved Sequence , Humans , Magnetic Resonance Spectroscopy , Models, Biological , Models, Molecular , Molecular Sequence Data , Neoplasm Proteins/metabolism , Protein Conformation , Protein Structure, Secondary , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Transcription Factor TFIIH , Transcription Factors/metabolism , Transcription, Genetic , Zinc/metabolism , Zinc Fingers
15.
Mol Cell Endocrinol ; 163(1-2): 33-42, 2000 May 25.
Article in English | MEDLINE | ID: mdl-10963871

ABSTRACT

In mammals, the mechanisms triggering initiation of follicular growth remain largely unknown. The present study constitutes an attempt to relate morphological and functional changes occuring in follicles at the time of transition from the nongrowing to the early growing stage. The population of very small follicles, including both nongrowing and early growing follicles, has been studied in fetal and adult monkey (Macaca fascicularis). Counts of these follicles and immunohistochemical analyses of their content in various intraovarian peptides led to the conclusion that initiation is probably not similar, on a quantitative as well as a qualitative point of view, in the fetal and in the adult ovary. In addition to the recently evidenced stimulatory role of the stem cell factor (SCF) in rats, activation of a nongrowing follicle might imply an arrest in the production of inhibiting factors, such as the transforming growth factor-beta2 (TGF-beta2), occurring simultaneously with the production of stimulatory factors, such as the transforming growth factor-alpha (TGFalpha).


Subject(s)
Intercellular Signaling Peptides and Proteins , Ovarian Follicle/physiology , Adult , Animals , Bone Morphogenetic Protein 15 , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Female , Fetus , Growth Differentiation Factor 9 , Growth Substances/metabolism , Humans , Immunohistochemistry , Macaca fascicularis , Ovarian Follicle/embryology , Ovarian Follicle/growth & development , Ovarian Follicle/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Stem Cell Factor/metabolism , Transforming Growth Factor alpha/metabolism , Transforming Growth Factor beta/metabolism
16.
Mol Reprod Dev ; 56(2): 180-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10813850

ABSTRACT

Rat epididymal glycoprotein DE associates with the dorsal region of the sperm head during sperm maturation, migrates to the equatorial segment (ES) with the acrosome reaction (AR), and is involved in gamete membrane fusion. In the present study we examined the association of DE with the sperm surface and the relationship of this interaction with the behavior and function of the protein. Cloning and sequencing of DE revealed a lack of hydrophobic domains and the presence of 16 cysteine residues in the molecule. Experiments in which cauda epididymal sperm were subjected to different extraction procedures indicated that while most of the protein is removable from sperm by mild ionic strength, a low amount of DE, resistant to even 2 M NaCl, can be completely extracted by agents that remove integral proteins. However, the lack of hydrophobic domains in the molecule and the failure of DE to interact with liposomes, does not support a direct insertion of the protein into the lipid bilayer. These results, and the complete extraction of the tightly bound protein by dithiothreitol, suggest that this population would correspond to a peripheral protein bound to a membrane component by strong noncovalent interactions that involve disulfide bonds. While ELISA experiments showed that no protein could be extracted by NaCl from capacitated sperm, indirect immunofluorescence studies revealed the ability of the NaCl-resistant protein to migrate to the ES. Together, these results support the existence of two populations of DE: a major, loosely bound population that is released during capacitation, and a minor strongly bound population that remains after capacitation, migrates to the ES with the AR, and thus would correspond to the one with a role in gamete fusion.


Subject(s)
Metalloproteins/metabolism , Spermatozoa/metabolism , Testicular Hormones/metabolism , Animals , Cell Membrane/metabolism , Cloning, Molecular , Epididymal Secretory Proteins , Male , Metalloproteins/genetics , Rats , Rats, Sprague-Dawley , Sperm Capacitation/physiology , Testicular Hormones/genetics
17.
J Biol Chem ; 275(30): 22815-23, 2000 Jul 28.
Article in English | MEDLINE | ID: mdl-10801852

ABSTRACT

The transcription/DNA repair factor TFIIH may be resolved into at least two subcomplexes: the core TFIIH and the cdk-activating kinase (CAK) complex. The CAK complex, which is also found free in the cell, is composed of cdk7, cyclin H, and MAT1. In the present work, we found that the C terminus of MAT1 binds to the cdk7 x cyclin H complex and activates the cdk7 kinase activity. The median portion of MAT1, which contains a coiled-coil motif, allows the binding of CAK to the TFIIH core through interactions with both XPD and XPB helicases. Furthermore, using recombinant TFIIH complexes, it is demonstrated that the N-terminal RING finger domain of MAT1 is crucial for transcription activation and participates to the phosphorylation of the C-terminal domain of the largest subunit of the RNA polymerase II.


Subject(s)
Cyclin-Dependent Kinases , Gene Expression Regulation, Enzymologic/physiology , Protein Serine-Threonine Kinases/physiology , Transcription Factors, TFII , Transcription Factors/metabolism , Transcription, Genetic/physiology , Amino Acid Sequence , Animals , Cell Line , Cyclin H , Cyclins/metabolism , DNA Helicases/metabolism , Molecular Sequence Data , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Spodoptera , Substrate Specificity , Transcription Factor TFIIH , Cyclin-Dependent Kinase-Activating Kinase
18.
Mol Cell ; 3(1): 87-95, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10024882

ABSTRACT

To understand the initiation of the transcription of protein-coding genes, we have dissected the role of the basal transcription/DNA repair factor TFIIH. Having succeeded in reconstituting a functionally active TFIIH from baculovirus recombinant polypeptides, we were able to analyze the role of XPB, XPD, and cdk7 subunits in the transcription reaction. Designing mutated recombinant subunits, we show that the XPB helicase is absolutely required for transcription to open the promoter around the start site whereas the XPD helicase, which is dispensable, stimulates transcription and allows the CAK complex to be anchored to TFIIH. In addition, we also show that cdk7 may phosphorylate the carboxy-terminal domain (CTD) of RNA pol II in the absence of promoter opening.


Subject(s)
Cyclin-Dependent Kinases , Transcription Factors, TFII/genetics , Transcription Factors , Transcription, Genetic/genetics , Baculoviridae/genetics , DNA Helicases/genetics , DNA Helicases/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , HeLa Cells , Humans , Mutation/genetics , Promoter Regions, Genetic/genetics , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Proteins/genetics , Proteins/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription Factors, TFII/metabolism , Xeroderma Pigmentosum Group D Protein , Cyclin-Dependent Kinase-Activating Kinase
19.
EMBO J ; 16(5): 958-67, 1997 Mar 03.
Article in English | MEDLINE | ID: mdl-9118957

ABSTRACT

The crystal structure of human cyclin H refined at 2.6 A resolution is compared with that of cyclin A. The core of the molecule consists of two repeats containing five helices each and forming the canonical cyclin fold also observed in TFIIB. One hundred and thirty-two out of the 217 C alpha atoms from the cyclin fold can be superposed with a root-mean-square difference of 1.8 A. The structural homology is even higher for the residues at the interface with the kinase, which is of functional significance, as shown by our observation that cyclin H binds to cyclin-dependent kinase 2 (cdk2) and that cyclin A is able to activate cdk7 in the presence of MAT1. Based on this superposition, a new signature sequence for cyclins was found. The specificity of the cyclin H molecule is provided mainly by two long helices which extend the cyclin fold at its N- and C-termini and pack together against the first repeat on the side opposite to the kinase. Deletion mutants show that the terminal helices are required for a functionally active cyclin H.


Subject(s)
Cyclin-Dependent Kinases/metabolism , Cyclins/chemistry , Enzyme Activation/physiology , Amino Acid Sequence , Blotting, Western , Conserved Sequence , Crystallography, X-Ray , Cyclin H , Cyclins/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Mutation/genetics , Protein Conformation , Protein Folding , Protein Structure, Secondary , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Repetitive Sequences, Nucleic Acid , Sequence Alignment , Sequence Deletion/genetics , Sequence Homology, Amino Acid
20.
Protein Expr Purif ; 9(2): 153-8, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9056480

ABSTRACT

The human cyclin H, a protein normally associated with the cyclin-dependent kinase cdk7, was overexpressed in Escherichia coli using a T7 RNA polymerase expression system and further purified to apparent homogeneity. The purified recombinant cyclin H is similar to the endogenous one according to the following criteria: molecular weight, microsequencing and mass spectra studies, ability to interact with cdk7, and regulatory kinase activity. The scale-up of cyclin H purification is described.


Subject(s)
Cyclins/isolation & purification , Escherichia coli/genetics , Genetic Vectors/metabolism , Affinity Labels , Amino Acid Sequence , Blotting, Western , Cyclin H , Cyclins/biosynthesis , Cyclins/chemistry , Escherichia coli/chemistry , Genetic Vectors/chemistry , Humans , Molecular Sequence Data , Protein Binding/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Transcription Factors, TFII/biosynthesis , Transcription Factors, TFII/chemistry , Transcription Factors, TFII/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...